Nearly half of all CRC tumors have activating mutations in either of the smallGTPases, KRAS and BRAF, which activate the MAPkinase (MAPK) pathway and stimulate cell proliferation (Cancer Genome Atlas Network, 2012; Guinney et al., 2015). This evidence concerns the gene BRAF and colorectal carcinoma.